Evercore ISI's analysis indicates that 2025 is expected to be a year of stabilization or slight improvement for CVS Health's Health Care Benefits (HCB) segment. The firm forecasts an approximate ...

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...

Evercore (NYSE: EVR) announced today that Joe Modisett has joined the firm as a senior managing director in the Healthcare Investment Banking group, based in New York. Naveen Nataraj, co-head of U ...

Fintel reports that on March 12, 2025, Evercore ISI Group initiated ... hospital infectious disease care givers, community based infectious disease healthcare providers, as well as healthcare ...

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on Health Catalyst (HCAT – Research Report) yesterday and set a price target of $6.00. The company’s shares closed yesterday ...

Evercore ISI analysts warned in a note Monday that stagflation fears are mounting, with tariff policies and economic uncertainty creating potential downside risks for the S&P 500.

Welltower (NYSE:WELL – Get Free Report) had its target price raised by investment analysts at Evercore ISI from $144.00 to $145.00 in a research note issued to investors on Tuesday,Benzinga reports.

NEW YORK, March 03, 2025--(BUSINESS WIRE)--Evercore (NYSE: EVR) announced today that Joe Modisett has joined the firm as a senior managing director in the Healthcare Investment Banking group ...

NEW YORK, March 03, 2025--(BUSINESS WIRE)--Evercore (NYSE: EVR) announced today that Joe Modisett has joined the firm as a senior managing director in the Healthcare Investment Banking group, based in ...